Improving Cancer Detection and Treatment by pH‐Sensitive Peptide Nanoparticle Drug Delivery Platform: Pharmacokinetics, Toxicity, and Immunogenicity Profile
Open Access
- 30 December 2021
- journal article
- research article
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 2 (3) , 2100081
Abstract
It was previously reported that a nanoparticle made of ultra pH‐sensitive peptides (pH‐NP) undergoes self‐dissolution in moderately acidic (pH ≤ 6.9) condition that mimics the pH in extracellular tumor environment, leading to release of drug cargo molecules. Herein, it is demonstrated that this peptide‐based nanodelivery platform can be used to formulate poorly water‐soluble small molecules to improve cancer diagnosis and treatment. Indocyanine green (ICG) encapsulated in pH‐NP (ICG‐pH‐NP) significantly increases tumor‐specific accumulation compared with “free” ICG, leading to excellent in vivo optical imaging contrast. An investigational cancer drug, OTS964, formulated in pH‐NP (OTS‐pH‐NP), sensitizes the drug‐resistant triple‐negative breast cancer to chemotherapy (paclitaxel), resulting in a remarkable tumor regression, whereas OTS964 in standard formulation does not (P = 0.0004). The potential immunogenicity and bone marrow toxicity of this nanoparticle are further investigated by administering drug‐free pH‐NP at nanoparticle dose regimens, representing 1.5× and 4.5×, respectively, of which are used in the treatment (OTS‐pH‐NP) study. The data show that the pH‐NP is not immunogenic and is well‐tolerated. Taken together, self‐dissolution and the release of drug cargo in response to the tumor's acidic extracellular pH faciliates drug delivery when mediated by the pH‐NP nano platform, making it a promising, clinical translational delivery platform for enhancing cancer detection and treatment.Keywords
Funding Information
- National Institutes of Health (R21CA198563, U24CA231858)
This publication has 39 references indexed in Scilit:
- Desensitization to Liposomal Amphotericin B after Anaphylactic ReactionJournal of Allergy and Clinical Immunology, 2012
- Normalization of the Vasculature for Treatment of Cancer and Other DiseasesPhysiological Reviews, 2011
- Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicityChemico-Biological Interactions, 2011
- Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL/6J, 129SV/EV and C3H/HeJ Mouse StrainsPLOS ONE, 2008
- Drug Resistance and the Solid Tumor MicroenvironmentJNCI: Journal of the National Cancer Institute, 2007
- PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast CancerCancer Research, 2006
- Antigenicity and Immunogenicity of Synthetic PeptidesBiologicals, 2001
- Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlationNature Medicine, 1997
- Anaphylactic reactions to liposomal amphotericinThe Lancet, 1994
- INDOCYANINE GREEN: OBSERVATIONS ON ITS PHYSICAL PROPERTIES, PLASMA DECAY, AND HEPATIC EXTRACTION*Journal of Clinical Investigation, 1960